SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Amundi S.A. (AMDUF) trades at a trailing P/E of 10.1, forward P/E of 10.3. Trailing earnings yield is 9.95%, forward earnings yield 9.75%. PEG 0.33 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (10.1); PEG ≤ 1.0 — Peter Lynch undervalued (0.33); earnings yield beats bond yields (9.95%).
- PEG Ratio 0.33 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 9.95% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 76/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AMDUF
Valuation Multiples
P/E (TTM)10.1
Forward P/E10.3
PEG Ratio0.33
Forward PEG2.93
P/B Ratio0.00
P/S Ratio4.79
EV/EBITDA0.0
Per Share Data
EPS (TTM)$8.33
Forward EPS (Est.)$8.16
Book Value / Share$0.00
Revenue / Share$17.49
FCF / Share$0.00
Yields & Fair Value
Earnings Yield9.95%
Forward Earnings Yield9.75%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$3.40 |
$2.62B |
$568.27M |
21.7% |
| 2017 |
$3.54 |
$3.95B |
$681.29M |
17.3% |
| 2018 |
$4.24 |
$4.8B |
$855M |
17.8% |
| 2019 |
$4.75 |
$4.73B |
$959.28M |
20.3% |
| 2020 |
$4.50 |
$4.57B |
$909.8M |
19.9% |
| 2021 |
$6.75 |
$5.79B |
$1.37B |
23.6% |
| 2022 |
$5.28 |
$5.87B |
$1.07B |
18.3% |
| 2023 |
$5.70 |
$6B |
$1.16B |
19.4% |
| 2024 |
$6.37 |
$6.19B |
$1.31B |
21.1% |
| 2025 |
$8.33 |
$3.34B |
$1.59B |
47.6% |
